ID   NF2L2_RAT               Reviewed;         604 AA.
AC   O54968; Q6P7C8;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 2.
DT   02-OCT-2024, entry version 175.
DE   RecName: Full=Nuclear factor erythroid 2-related factor 2 {ECO:0000303|PubMed:12198130};
DE            Short=NF-E2-related factor 2 {ECO:0000303|PubMed:12198130};
DE            Short=NFE2-related factor 2 {ECO:0000303|PubMed:12198130};
DE   AltName: Full=Nuclear factor, erythroid derived 2, like 2 {ECO:0000250|UniProtKB:Q16236};
GN   Name=Nfe2l2 {ECO:0000312|RGD:620360};
GN   Synonyms=Nrf2 {ECO:0000303|PubMed:12198130};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   STRAIN=Wistar; TISSUE=Liver;
RA   Sakai M., Ito M., Sasaki K., Nishi S.;
RL   Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION AT SER-40, AND MUTAGENESIS OF SER-40.
RX   PubMed=12198130; DOI=10.1074/jbc.m206911200;
RA   Huang H.-C., Nguyen T., Pickett C.B.;
RT   "Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates
RT   antioxidant response element-mediated transcription.";
RL   J. Biol. Chem. 277:42769-42774(2002).
RN   [4]
RP   FUNCTION, INTERACTION WITH CHD6 AND MAFK, SUBCELLULAR LOCATION, AND REGION.
RX   PubMed=16314513; DOI=10.1128/mcb.25.24.10895-10906.2005;
RA   Nioi P., Nguyen T., Sherratt P.J., Pickett C.B.;
RT   "The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional
RT   activation.";
RL   Mol. Cell. Biol. 25:10895-10906(2005).
CC   -!- FUNCTION: Transcription factor that plays a key role in the response to
CC       oxidative stress: binds to antioxidant response (ARE) elements present
CC       in the promoter region of many cytoprotective genes, such as phase 2
CC       detoxifying enzymes, and promotes their expression, thereby
CC       neutralizing reactive electrophiles (PubMed:16314513). In normal
CC       conditions, ubiquitinated and degraded in the cytoplasm by the
CC       BCR(KEAP1) complex. In response to oxidative stress, electrophile
CC       metabolites inhibit activity of the BCR(KEAP1) complex, promoting
CC       nuclear accumulation of NFE2L2/NRF2, heterodimerization with one of the
CC       small Maf proteins and binding to ARE elements of cytoprotective target
CC       genes. The NFE2L2/NRF2 pathway is also activated in response to
CC       selective autophagy: autophagy promotes interaction between KEAP1 and
CC       SQSTM1/p62 and subsequent inactivation of the BCR(KEAP1) complex,
CC       leading to NFE2L2/NRF2 nuclear accumulation and expression of
CC       cytoprotective genes (By similarity). May also be involved in the
CC       transcriptional activation of genes of the beta-globin cluster by
CC       mediating enhancer activity of hypersensitive site 2 of the beta-globin
CC       locus control region (By similarity). Also plays an important role in
CC       the regulation of the innate immune response. It is a critical
CC       regulator of the innate immune response and survival during sepsis by
CC       maintaining redox homeostasis and restraint of the dysregulation of
CC       pro-inflammatory signaling pathways like MyD88-dependent and
CC       -independent and TNF-alpha signaling. Suppresses macrophage
CC       inflammatory response by blocking pro-inflammatory cytokine
CC       transcription and the induction of IL6. Binds to the proximity of pro-
CC       inflammatory genes in macrophages and inhibits RNA Pol II recruitment.
CC       The inhibition is independent of the Nrf2-binding motif and reactive
CC       oxygen species level (By similarity). Represses antiviral cytosolic DNA
CC       sensing by suppressing the expression of the adapter protein STING1 and
CC       decreasing responsiveness to STING1 agonists while increasing
CC       susceptibility to infection with DNA viruses (By similarity).
CC       {ECO:0000250|UniProtKB:Q16236, ECO:0000250|UniProtKB:Q60795,
CC       ECO:0000269|PubMed:16314513}.
CC   -!- SUBUNIT: Heterodimer; heterodimerizes with small Maf proteins
CC       (PubMed:16314513). Interacts (via the bZIP domain) with MAFG and MAFK;
CC       required for binding to antioxidant response elements (AREs) on DNA
CC       (PubMed:16314513). Interacts with KEAP1; the interaction is direct and
CC       promotes ubiquitination by the BCR(KEAP1) E3 ubiquitin ligase complex
CC       (By similarity). Forms a ternary complex with PGAM5 and KEAP1.
CC       Interacts with EEF1D at heat shock promoter elements (HSE) (By
CC       similarity). Interacts via its leucine-zipper domain with the coiled-
CC       coil domain of PMF1 (By similarity). Interacts with CHD6; involved in
CC       activation of the transcription (PubMed:16314513). Interacts with
CC       ESRRB; represses NFE2L2 transcriptional activity (By similarity).
CC       Interacts with MOTS-c, a peptide produced by the mitochondrially
CC       encoded 12S rRNA MT-RNR1; the interaction occurs in the nucleus
CC       following metabolic stress (By similarity).
CC       {ECO:0000250|UniProtKB:Q16236, ECO:0000250|UniProtKB:Q60795,
CC       ECO:0000269|PubMed:16314513}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q60795}. Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00978, ECO:0000269|PubMed:16314513}. Note=Cytosolic under
CC       unstressed conditions: ubiquitinated and degraded by the BCR(KEAP1) E3
CC       ubiquitin ligase complex. Translocates into the nucleus upon induction
CC       by electrophilic agents that inactivate the BCR(KEAP1) E3 ubiquitin
CC       ligase complex. {ECO:0000250|UniProtKB:Q60795}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O54968-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O54968-2; Sequence=VSP_025046;
CC   -!- DOMAIN: The ETGE motif, and to a lower extent the DLG motif, mediate
CC       interaction with KEAP1. {ECO:0000250|UniProtKB:Q60795}.
CC   -!- PTM: Ubiquitinated in the cytoplasm by the BCR(KEAP1) E3 ubiquitin
CC       ligase complex leading to its degradation. In response to oxidative
CC       stress, electrophile metabolites, such as sulforaphane, modify KEAP1,
CC       leading to inhibit activity of the BCR(KEAP1) complex, promoting
CC       NFE2L2/NRF2 nuclear accumulation and activity. In response to
CC       autophagy, the BCR(KEAP1) complex is inactivated.
CC       {ECO:0000250|UniProtKB:Q60795}.
CC   -!- PTM: Phosphorylation of Ser-40 by PKC in response to oxidative stress
CC       dissociates NFE2L2 from its cytoplasmic inhibitor KEAP1, promoting its
CC       translocation into the nucleus. {ECO:0000269|PubMed:12198130}.
CC   -!- PTM: Acetylation at Lys-595 and Lys-598 increases nuclear localization
CC       whereas deacetylation by SIRT1 enhances cytoplasmic presence.
CC       {ECO:0000250|UniProtKB:Q16236}.
CC   -!- PTM: Glycation impairs transcription factor activity by preventing
CC       heterodimerization with small Maf proteins. Deglycation by FN3K
CC       restores activity. {ECO:0000250|UniProtKB:Q16236}.
CC   -!- SIMILARITY: Belongs to the bZIP family. CNC subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF037350; AAB92256.1; -; mRNA.
DR   EMBL; BC061724; AAH61724.1; -; mRNA.
DR   RefSeq; NP_113977.1; NM_031789.2. [O54968-2]
DR   RefSeq; XP_006234458.1; XM_006234396.3.
DR   AlphaFoldDB; O54968; -.
DR   SMR; O54968; -.
DR   BioGRID; 249784; 2.
DR   STRING; 10116.ENSRNOP00000002114; -.
DR   ChEMBL; CHEMBL1075141; -.
DR   GlyCosmos; O54968; 6 sites, No reported glycans.
DR   iPTMnet; O54968; -.
DR   PhosphoSitePlus; O54968; -.
DR   PaxDb; 10116-ENSRNOP00000002114; -.
DR   Ensembl; ENSRNOT00000002114.7; ENSRNOP00000002114.6; ENSRNOG00000001548.7. [O54968-1]
DR   GeneID; 83619; -.
DR   KEGG; rno:83619; -.
DR   UCSC; RGD:620360; rat. [O54968-1]
DR   AGR; RGD:620360; -.
DR   CTD; 4780; -.
DR   RGD; 620360; Nfe2l2.
DR   eggNOG; KOG3863; Eukaryota.
DR   GeneTree; ENSGT00950000182892; -.
DR   InParanoid; O54968; -.
DR   OMA; DMEEMDQ; -.
DR   OrthoDB; 382726at2759; -.
DR   PhylomeDB; O54968; -.
DR   Reactome; R-RNO-8951664; Neddylation.
DR   Reactome; R-RNO-9755511; KEAP1-NFE2L2 pathway.
DR   Reactome; R-RNO-9759194; Nuclear events mediated by NFE2L2.
DR   Reactome; R-RNO-9762114; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2.
DR   PRO; PR:O54968; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000001548; Expressed in stomach and 20 other cell types or tissues.
DR   GO; GO:0005813; C:centrosome; IEA:Ensembl.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0016592; C:mediator complex; ISO:RGD.
DR   GO; GO:0043228; C:non-membrane-bounded organelle; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0032993; C:protein-DNA complex; ISO:RGD.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0140693; F:molecular condensate scaffold activity; ISO:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; IDA:UniProtKB.
DR   GO; GO:0001221; F:transcription coregulator binding; IPI:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0046223; P:aflatoxin catabolic process; IMP:RGD.
DR   GO; GO:0045454; P:cell redox homeostasis; IMP:UniProtKB.
DR   GO; GO:1904385; P:cellular response to angiotensin; IDA:RGD.
DR   GO; GO:0071280; P:cellular response to copper ion; ISO:RGD.
DR   GO; GO:0071498; P:cellular response to fluid shear stress; ISS:UniProtKB.
DR   GO; GO:0042149; P:cellular response to glucose starvation; ISO:RGD.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; ISO:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0071499; P:cellular response to laminar fluid shear stress; ISO:RGD.
DR   GO; GO:0061431; P:cellular response to methionine; IEP:RGD.
DR   GO; GO:0034599; P:cellular response to oxidative stress; ISS:UniProtKB.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; ISO:RGD.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; ISO:RGD.
DR   GO; GO:0006954; P:inflammatory response; ISO:RGD.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IMP:RGD.
DR   GO; GO:1900038; P:negative regulation of cellular response to hypoxia; IMP:RGD.
DR   GO; GO:2000352; P:negative regulation of endothelial cell apoptotic process; ISO:RGD.
DR   GO; GO:0110076; P:negative regulation of ferroptosis; ISS:UniProtKB.
DR   GO; GO:1902037; P:negative regulation of hematopoietic stem cell differentiation; ISO:RGD.
DR   GO; GO:1902176; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:1904753; P:negative regulation of vascular associated smooth muscle cell migration; IMP:RGD.
DR   GO; GO:0036499; P:PERK-mediated unfolded protein response; ISO:RGD.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IMP:RGD.
DR   GO; GO:0030194; P:positive regulation of blood coagulation; ISO:RGD.
DR   GO; GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IMP:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:RGD.
DR   GO; GO:0046326; P:positive regulation of glucose import; ISO:RGD.
DR   GO; GO:1903788; P:positive regulation of glutathione biosynthetic process; ISO:RGD.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IMP:RGD.
DR   GO; GO:2000379; P:positive regulation of reactive oxygen species metabolic process; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0010499; P:proteasomal ubiquitin-independent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; ISS:UniProtKB.
DR   GO; GO:1900407; P:regulation of cellular response to oxidative stress; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0045995; P:regulation of embryonic development; ISO:RGD.
DR   GO; GO:0045088; P:regulation of innate immune response; ISS:UniProtKB.
DR   GO; GO:2000121; P:regulation of removal of superoxide radicals; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; ISO:RGD.
DR   GO; GO:0002931; P:response to ischemia; IEP:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   CDD; cd14720; bZIP_NFE2-like; 1.
DR   Gene3D; 1.10.880.10; Transcription factor, Skn-1-like, DNA-binding domain; 1.
DR   InterPro; IPR004827; bZIP.
DR   InterPro; IPR004826; bZIP_Maf.
DR   InterPro; IPR046347; bZIP_sf.
DR   InterPro; IPR047167; NFE2-like.
DR   InterPro; IPR008917; TF_DNA-bd_sf.
DR   PANTHER; PTHR24411; NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR; 1.
DR   PANTHER; PTHR24411:SF3; NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2; 1.
DR   Pfam; PF03131; bZIP_Maf; 1.
DR   SMART; SM00338; BRLZ; 1.
DR   SUPFAM; SSF47454; A DNA-binding domain in eukaryotic transcription factors; 1.
DR   SUPFAM; SSF57959; Leucine zipper domain; 1.
DR   PROSITE; PS50217; BZIP; 1.
DR   PROSITE; PS00036; BZIP_BASIC; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Alternative splicing; Cytoplasm; DNA-binding;
KW   Glycation; Glycoprotein; Nucleus; Phosphoprotein; Reference proteome;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN           1..604
FT                   /note="Nuclear factor erythroid 2-related factor 2"
FT                   /id="PRO_0000076451"
FT   DOMAIN          496..559
FT                   /note="bZIP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          334..447
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          498..517
FT                   /note="Basic motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          521..528
FT                   /note="Leucine-zipper"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          570..604
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          590..595
FT                   /note="Mediates interaction with CHD6 and is necessary to
FT                   activate transcription"
FT                   /evidence="ECO:0000269|PubMed:16314513"
FT   MOTIF           29..31
FT                   /note="DLG motif"
FT                   /evidence="ECO:0000250|UniProtKB:Q60795"
FT   MOTIF           79..82
FT                   /note="ETGE motif"
FT                   /evidence="ECO:0000250|UniProtKB:Q60795"
FT   COMPBIAS        334..358
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        387..430
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         40
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000269|PubMed:12198130"
FT   MOD_RES         214
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16236"
FT   MOD_RES         595
FT                   /note="N6-acetyllysine; by CREBBP"
FT                   /evidence="ECO:0000250|UniProtKB:Q16236"
FT   MOD_RES         598
FT                   /note="N6-acetyllysine; by CREBBP"
FT                   /evidence="ECO:0000250|UniProtKB:Q16236"
FT   CARBOHYD        461
FT                   /note="N-linked (Glc) (glycation) lysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16236"
FT   CARBOHYD        471
FT                   /note="N-linked (Glc) (glycation) lysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16236"
FT   CARBOHYD        486
FT                   /note="N-linked (Glc) (glycation) lysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16236"
FT   CARBOHYD        498
FT                   /note="N-linked (Glc) (glycation) arginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16236"
FT   CARBOHYD        568
FT                   /note="N-linked (Glc) (glycation) arginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16236"
FT   CARBOHYD        573
FT                   /note="N-linked (Glc) (glycation) lysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16236"
FT   VAR_SEQ         135..141
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_025046"
FT   MUTAGEN         40
FT                   /note="S->A: Fails to dissociate from KEAP1 after PKC
FT                   activation."
FT                   /evidence="ECO:0000269|PubMed:12198130"
SQ   SEQUENCE   604 AA;  67703 MW;  A07478F07F0C90B2 CRC64;
     MMDLELPPPG LQSQQDMDLI DILWRQDIDL GVSREVFDFS QRQKDYELEK QKKLEKERQE
     QLQKEQEKAF FAQLQLDEET GEFLPIQPAQ HIQTDTSGSV SYSQVAHIPK QDALYFEDCM
     QLLAETFPFV DDHEVSSPTF QSLALDIPSH VESSVFTTPD QAQSLDSSLE TAMTDLSSIQ
     QDMEQVWQEL FSIPELQCLN TENKQQAETT TVPSPEATLT EMDSNYHFYS SIPSLEKEVD
     SCSPHFLHGF EDSFSSILST DDASQLNSLD SNPTLNTDFG DEFYSAFLAE PSGGGSMPSS
     AAISQSLSEL LGGPIEGCDL SLCKAFNQKH TEGTVEFNDS DSGISLNTSP SRASPEHSVE
     SSIYGDPPPG FSDSEMEELD SAPGSVKQNG PKAQPTHSSG DTVQPLSPAQ GHSAAVHESQ
     CENTTKKEVP VSPGHQKVPF TKDKHSSRLE AHLTRDELRA KALHIPFPVE KIINLPVDDF
     NEMMSKEQFN EAQLALIRDI RRRGKNKVAA QNCRKRKLEN IVELEQDLGH LKDEREKLLR
     EKGENDRNLH LLKRKLSTLY LEVFSMLRDE DGKPYSPSEY SLQQTRDGNV FLVPKSKKPD
     TKKN
//
